Member Info for lignumvitae

Apparently the company (PL) values its retail shareholder base.

How does it demonstrate this love affair?

Announcement of Retail Offer @ 5:28pm - Closure of Retail Offer @ 9:00pm

So let's take an example of a recipient of this love. Mr Eternal Optimist has been running a bit late. He leaves the office at around 5:30 - just gets the train around 6:15 - gets to his destination into the car & the inevitable traffic & home around 8:00 & (by then whacked) a quick meal & "Oh yes - let's check on Atom" - knowing he is a valued shareholder.

So, a system rigged against the PBPI (Poor (in two senses) B....y Private Investor who now feels not to be a valued PI but a devalued PI.

We are told that the Atome offer price is referenced to the share price on 9th April - accordingly subsequent to that there has essentially a false market with no guidance from management.

Not good.

Management can always devise innovative ways to enrich themselves - so how about putting those brains to really showing appreciation to PI's - So how about to a warrant issue to shareholders of record at close on Wednesday - excluding those who had the opportunity to participate in the placing. Wouldn't be too difficult, would it? And it might, just might, restore an element of trust.

I rest my case.

Shafted is the word that comes to mind.

So, we must exercise patience for another couple of days. Let us all hope that it is worth it.

Well the IMF/World Bank meeting ended Saturday so did all the remaining points of difference get ironed out & did we finally get Equity Club sign off?

We have been told that Villeta 1 will be financed at subsidiary level with Atome retaining a carried interest (20%?) so obviously the equity subscription total & pricing will give a direct read-through to Atome. But will there be a lock-in period? Will there be a timeline for the new subsidiary to have its own listing? What will be the terms of the Atome management/services agreement?

Then we shall see how 'sticky' the new shareholders are which could well give a rarity value to Atome.

Exciting times ahead so long as sign-off has happened & on favourable terms.

The question is whether these missed deadlines were agreed by the auditors & if so then they are at fault.

OR have they indicated that their report may include a qualification & this is the matter of dispute & delay.

Soon all will be revealed but unsatisfactory nonetheless.

NOT a very pleasant way to start the day. Reads quite well until they suddenly drop in - Oh, by the way Turner Pope (Undertakers to aspiring companies running short of cash) gave us a call. Thought we might be interested in a nice discounted fundraise.

Yes, of course we had indicated that we were OK for cash and a raise was not planned but what a chance to enrich the pockets of the TP placees. Just a small discount until you take account of the leak inspired drop which puts it at around 20%.

Then there the obligatory dishing out of the share options. Poor little darlings haven't received a bonus (what for one might ask) & their salaries are below the benchmark apparently which smacks of marking their own homework.

And who suffers - inevitably the PI's.

I am wondering whether this is anything other than a lifestyle company.

Yes, Tempus is a mammoth with real clout. So, apart from commercially being potentially transformational for Renalytix this puts it firmly on the global radar.

Kindney disease is a huge & underserved market - has Renalytix time finally come?

Well, if you are a Director & want to send a signal, then buy an additional 5 million shares. Well done Dr Hargreaves. This should set a solid floor for Aptamer.

I have made one previous comment on this stock.

In their one and only reference to the share price, ahead of the fund raise announcement of 28 August the company warned that the new investment would take place at a significant discount to the then share price.

There have been no further substantive announcements despite this being, for the present a Main Market stock - ie not swimming in the shark infested waters of AIM.

Investors must make their own decisions but please do the mathematics - the fundraise announcement seems designed to obfuscate more than illuminate. With the now share price indicating an entry point of some 20 times that of the new investors then they(ie the new investors) must currently be licking their lips.

Let's face it, in the investment world burnt fingers are one thing - amputations are quite another.

I can say no more - maybe I am wrong & others right. Meanwhile I have made a vow to make no further comment on Cykel.

Unless my mathematics is wrong PI buyers are now paying some 16 times, ie 1600% that being paid by the new kids on the block. Hmmm ?

The tide appears to be turning in OXB's favour. Today's positive RNS has provided the opportunity for weak holders to exit stage left

...... that is the question.

With a Mkt Cap of around just £3.5m is this an undiscovered Great British tech star in the making - a little gem to be bought

and locked away OR yet another tiddler which promises much yet delivers little.

Well, they are due to release figures for the 6 months to 30 June this month and the most recent guide in this regard is the comprehensive trading update of 31 July & this reads very well. Current management appears to be competent and the strategy seems to be a "steady as you go" build in sales to get to a cash burn neutral position. If they can do that without another raise that would be hugely positive.

The market for water testing, whether environmental or potable water is only going to grow. Weather / Climate change fluctuations between drought conditions and inundations can only increase the demand for testing and I note the aspiration "aiming to ..... establish Metir as the global leader in PFAS detection solutions" ie: not only among the leaders in water testing generally but THE leader in certain niche sectors. That is ambitious indeed!. Also Middle Eastern orders of significance demonstrate that their message is being listened to internationally.

Of course the company, under previous management, has disappointed before bot maybe its time has come. Nonetheless the cautious investoer may wish to wait until further evidence of progress has been demonstrated - the bolder will note the Mkt Cap & the potential if Metir can indeed establish a global presence in a market that is likely to grow exponentially & be aware that 'animal spirits' are being rediscovered in the search for the next overlooked opportunity.

It would appear that one of the new strategic investors is American company DEFI DEVELOPMENT who, according to HL analysis has a current market cap of $336 with a year low of $0.49 & high of $53.88 although currently back at around $16. Interesting - that is the sort of share price performance we could do with

The spectre at our particular feast is dilution. Today's announcement of 36m warrant exercise is Turner Pope (two words that should strike horror in the heart of PI's). These were the warrants granted to TP in the 2023 fundraising & they had an exercise price of 1p. But, if option/warrant exercise prices suddenly appear to be too demanding then they get rejigged downwards. Very nice little mechanism for insiders. Don't think a PI could just turn up & say "I bought these shares & now we have a fundraise at a big discount so i now sit at a big loss so can i have my purchase price adjusted?".

But for TP at the later placing at 0.2p that is exactly what they demanded and got - the 36m warrant exercise of 1.0p suddenly becomes .2p. NIce work TP.

So do we think they will now hold these shares? That is a question that takes a nanosecond to answer. After all they have further warrants at 0.2p & 0.3p from the subsequent fundraises.

So, this dilution & the large number of employee options mean that if the Aptamer share is to gather further pace from here then the announcements must continue to flow & they must be positive.

For what it is worth i continue to hold but am aware that the sharks are always waiting to nibble away at the flesh

What a very appropriate name. Nano= very small / Synth = synthetic.
Quite how this company continues to command a valuation of £26m is beyond me.

Robin Hood is depressed. His old method of people keeping hold of their entitlements & waging war against robber barons such as the Sherriff of Nottingham just ain't working anymore.
Now the message is: "Take from the poor - give to the rich"
Yes, total shafting & a virtually criminal disgrace.
Do we need any better example of how the system is rigged against PI's .
Too often, advisors, paid by the company [ie existing shareholders] seem to be working hand-in-glove with new investors to drive prices of new funding down.

Yes, certainly material &, might one say, a SUPER deal !

At last the fundamental value within Adriatic is being recognized.
As for anyone who takes their info from Hargreaves Lansdown they show the market cap as £580 which is actually the A$ cap.
There are 209m shares in issue = a cap @ £1.50 of some £313.
I continue to believe that this is a quality mid-cap mining company in the making.

If there's a decent turn
the placees will churn.
SIMPLE.
So expect a material drop in the share price. Whether this represents a good opportunity for averaging down or as a new entry point very much depends upon your view of the fundamental attractions of HEMO's scientific base.

Read through from Bacconora marks Ironridge out as being cheap - particularly post fundraising.
And then of course you have the gold.
Underappreciated by the market but that will change.
Patient holders take comfort.